Janux Therapeutics, Inc. (JANX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 42.37 |
| Open | 41.90 |
| Bid | 41.86 x 100 |
| Ask | 42.02 x 100 |
| Day's range | 41.02 - 42.92 |
| 52-week range | 5.65 - 65.60 |
| Volume | |
| Avg. volume | 818,133 |
| Market cap | 2.178B |
| Beta (5Y monthly) | 3.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.20 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 68.57 |
Barrons.comTruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors
Rorema Beheer disclosed a large position in healthcare IT solutions firm TruBridge. PL Capital Advisors increased its stake in regional bank Evans Bancorp.
Simply Wall St.We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Janux Therapeutics...
GuruFocus.comJanux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
Detailed Analysis of Janux Therapeutics' First Quarter 2024 Financials and Business Updates
© 2024 Yahoo. All rights reserved.